Cannabix Technologies Inc. (CSE: BLO) (OTCID: BLOZF) (Frankfurt: 8CT) (the “Company” or “Cannabix”) and Omega Laboratories, ...
Omega Laboratories, Inc. ("Omega"), and Cannabix Technologies Inc. ("Cannabix") (CSE: BLO) (OTCID: BLOZF) announce the development and validation of a DOT-like drug-test panel for breath testing. The ...
Cannabix Technologies Inc. (CSE: BLO) (OTCID: BLOZF) (Frankfurt: 8CT) (the "Company" or "Cannabix") and Omega Laboratories, ...
Automated quality control using rapid PCR assays is replacing 28-day culture tests, cutting biopharmaceutical lot release ...
Biopharmaceutical developers should introduce risk-based, phase-appropriate characterization strategies for quality control ...
Cannabix Technologies (CSE:BLO)(USOTC:BLOZF)(Frankfurt: 8CT)has announced a potentially transformative advancement in the ...
Morning Overview on MSN
A blood test can now flag Alzheimer’s three to four years before symptoms
Researchers at Washington University School of Medicine have developed a method to predict when a person will develop ...
The discovery of blood-based extracellular vesicles and particles carrying brain-specific information could help make ...
Morning Overview on MSN
A finger-prick test taken at home may reveal your dementia risk
Researchers have shown that a simple finger prick performed at home, without medical supervision, can detect a protein linked ...
As instruments grow faster, leaders say clinical impact will depend on trust, standards, data, and assays built for real ...
Candel Therapeutics (CADL) shifts to late-stage oncology with CAN-2409 Phase III wins and BLA catalyst. Read here for a ...
Circular Genomics today announced the launch of CircPATHtm, the company's proprietary circular RNA discovery and validation engine, following the publication of landmark findings in Nature Medicine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results